Should You Expect Conduit Pharmaceuticals Inc (NASDAQ:CDT) To Recover From Its 9.17% Gain From Highs?
Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s traded shares stood at 0.69 million during the last session, with the company’s beta value hitting 2.33. At the close of